OverviewChartNewsTraderScreen

BAVARIAN NOR NAM. DK 10/  DK0015998017  /

Düsseldorf
2024-05-15  4:30:46 PM Chg. +0.540 Volume Bid5:13:46 PM Ask5:13:46 PM High Low
22.810EUR +2.42% 0
Turnover: 0.000		 22.790Bid Size: 190 23.070Ask Size: 190 22.810 22.370
GlobeNewswire 04-29 Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chiku...
GlobeNewswire 04-02 Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
GlobeNewswire 02-23 Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines...
TeleTrader 2022-08-19 EU makes monkeypox vaccine more available
TeleTrader 2022-08-18 WH announces new strategies against monkeypox
TeleTrader 2022-07-30 Spain confirms second monkeypox death
TeleTrader 2022-07-29 Spain confirms Europe's first monkeypox death
TeleTrader 2022-07-25 Monkeypox vaccine approved by EU
TeleTrader 2022-07-22 EMA gives preliminary approval to monkeypox jab
GlobeNewswire 2022-03-21 Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Com...
GlobeNewswire 2022-02-28 Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead...
GlobeNewswire 2022-02-14 Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Pre...
GlobeNewswire 2021-12-06 Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening it...
GlobeNewswire 2021-12-05 Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
GlobeNewswire 2021-09-01 Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
GlobeNewswire 2021-08-23 Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of CO...
GlobeNewswire 2021-08-23 Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
GlobeNewswire 2021-08-09 Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine
GlobeNewswire 2021-06-11 Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox
GlobeNewswire 2021-03-08 Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-i...
GlobeNewswire 2020-12-16 Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
GlobeNewswire 2020-08-24 Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Small...
GlobeNewswire 2020-07-22 Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine
GlobeNewswire 2020-07-01 Bavarian Nordic Announces European Marketing Authorization for Ebola Vaccine
GlobeNewswire 2020-06-12 Bavarian Nordic to Manufacture Additional Ebola Vaccines for Janssen